MSDC-0160
MSDC-0160 is a prototype mTOR-modulating insulin sensitizer being studied to treat diabetes and Alzheimer’s disease.
| Trivial name | Mitoglitazone; CAY 10415 |
| Catalog Number | CSN17115 |
| Alternative Name(s) | Mitoglitazone; CAY 10415 |
| Research Area | Neurological Disease |
| Molecular Formula | C19H18N2O4S |
| CAS# | 146062-49-9 |
| Purity | ≥99% |
| SMILES | O=C(N1)SC(CC2=CC=C(OCC(C3=NC=C(CC)C=C3)=O)C=C2)C1=O |
| Size | 5mg |
| Supplier Page | https://www.csnpharm.com/products/msdc-0160.html |